INOVIO PHARMACEUTICALS, INC. - COMMON STOCK (INO)
CUSIP: 45773H409
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 69,182,326
- Total 13F shares
- 8,056,972
- Share change
- +3,985,719
- Total reported value
- $65,100,837
- Put/Call ratio
- 67%
- Price per share
- $8.08
- Number of holders
- 92
- Value change
- +$29,640,224
- Number of buys
- 49
- Number of sells
- 37
Quarterly Holders Quick Answers
What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45773H409:
Top shareholders of INO - INOVIO PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
1,594,385
|
$22,130,064 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.65%
|
450,266
|
$6,250,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.49%
|
339,686
|
$4,714,842 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.39%
|
267,802
|
$3,717,092 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
252,603
|
$3,506,926 | — | 31 Mar 2024 | |
| Jong Joseph Kim |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
3,113,086
mixed-class rows
|
$2,451,149 | — | 11 Mar 2022 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.15%
|
106,791
|
$1,482,259 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.13%
|
88,681
|
$1,230,892 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.12%
|
79,979
|
$1,110,000 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.11%
|
77,703
|
$1,078,518 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.11%
|
76,695
|
$1,064,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.1%
|
68,874
|
$955,971 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.08%
|
51,983
|
$721,524 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
49,052
|
$680,842 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
37,557
|
$521,291 | — | 31 Mar 2024 | |
| Green Alpha Advisors, LLC |
13F
|
Company |
0.05%
|
36,417
|
$505,468 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
35,180
|
$488,298 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
31,855
|
$442,147 | — | 31 Mar 2024 | |
| Marathon Trading Investment Management LLC |
13F
|
Company |
0.04%
|
30,300
|
$420,564 | — | 31 Mar 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.04%
|
29,918
|
$413,000 | — | 31 Mar 2024 | |
| GTS SECURITIES LLC |
13F
|
Company |
0.03%
|
23,479
|
$325,889 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.03%
|
22,246
|
$308,774 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.03%
|
21,721
|
$301,487 | — | 31 Mar 2024 | |
| Brevan Howard Capital Management LP |
13F
|
Company |
0.03%
|
21,237
|
$294,770 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.03%
|
20,261
|
$281,223 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.03%
|
19,465
|
$270,174 | — | 31 Mar 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.03%
|
17,690
|
$246,000 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.02%
|
16,497
|
$228,978 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.02%
|
15,451
|
$214,460 | — | 31 Mar 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.02%
|
15,245
|
$211,601 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
14,694
|
$203,953 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.02%
|
12,499
|
$174,000 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.02%
|
12,411
|
$172,264 | — | 31 Mar 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.02%
|
11,877
|
$164,853 | — | 31 Mar 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.02%
|
11,500
|
$159,620 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
11,075
|
$153,721 | — | 31 Mar 2024 | |
| Cedar Brook Financial Partners, LLC |
13F
|
Company |
0.02%
|
10,876
|
$150,959 | — | 31 Mar 2024 | |
| Keystone Financial Group |
13F
|
Company |
0.01%
|
10,307
|
$143,067 | — | 31 Mar 2024 | |
| Prime Capital Investment Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
10,172
|
$141,187 | — | 31 Mar 2024 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.01%
|
10,358
|
$135,897 | — | 31 Mar 2024 | |
| Amundi |
13F
|
Individual |
0.02%
|
11,606
|
$118,381 | — | 31 Mar 2024 | |
| Catalyst Funds Management Pty Ltd |
13F
|
Company |
0.01%
|
8,411
|
$116,745 | — | 31 Mar 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
6,693
|
$92,000 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
5,482
|
$76,085 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,412
|
$47,358 | — | 31 Mar 2024 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
1,968
|
$27,316 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,916
|
$26,595 | — | 31 Mar 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
1,733
|
$24,054 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,499
|
$20,807 | — | 31 Mar 2024 | |
| Headlands Technologies LLC |
13F
|
Company |
0%
|
1,360
|
$18,877 | — | 31 Mar 2024 |
Institutional Holders of INOVIO PHARMACEUTICALS, INC. - COMMON STOCK (INO) as of Q2 2024
As of 30 Jun 2024,
INOVIO PHARMACEUTICALS, INC. - COMMON STOCK (INO) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,056,972 shares.
The largest 10 holders included
Deep Track Capital, LP, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, Bank of New York Mellon Corp, and Qube Research & Technologies Ltd.
This page lists
92
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
83
Q2 2024 holders
92
Holder diff
9
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.